1.25%
25.52%
27.21%
16.75%
18.83%
10.61%
7.98%
AI Spotlight on DRW3
Company Description
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia.The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.It also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection.
The company's products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services.Its product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices.In addition, the company offers various training and services, as well as fire training facilities for firefighters.
Drägerwerk AG & Co. KGaA was founded in 1889 and is headquartered in Lübeck, Germany.
Market Data
| Last Price | 56.8 |
| Change Percentage | 1.25% |
| Open | 55.7 |
| Previous Close | 56.1 |
| Market Cap ( Millions) | 961 |
| Volume | 11093 |
| Year High | 57 |
| Year Low | 42.2 |
| M A 50 | 47.47 |
| M A 200 | 47.65 |
Financial Ratios
| FCF Yield | 14.77% |
| Dividend Yield | 3.17% |
| ROE | 7.94% |
| Debt / Equity | 20.57% |
| Net Debt / EBIDTA | 40.47% |
| Price To Book | 0.75 |
| Price Earnings Ratio | 9.53 |
| Price To FCF | 6.77 |
| Price To sales | 0.29 |
| EV / EBITDA | 3.78 |
News
- Jan -28 - Dräger receives Innovative Technology Designation from Vizient for Atlan® A350/ A350XL Anesthesia Machines
- Oct -30 - Draegerwerk AG & Co KGaA (DGWPF) Q3 2024 Earnings Call Highlights: Navigating Challenges ...
- Oct -16 - When It's Not a Drill: Dräger's New OXY SR Cap III Offers Life-saving Escape for Underground Workers
- Sep -24 - Dräger receives AARC's 2024 Zenith Award for support of respiratory care
- Apr -08 - Unlocking the Next Era: Dräger's Sneak Peek into the Future AirBoss SCBA
- Feb -29 - Dräger receives Frost & Sullivan's 2024 Best Practices Company of the Year Award in global respiratory care
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Medical
Expected Growth : 5 %
What the company do ?
Drägerwerk AG & Co. KGaA's Medical segment offers medical devices and solutions for hospitals, clinics, and patients, including ventilation, anesthesia, and patient monitoring systems.
Why we expect these perspectives ?
Drägerwerk's Medical segment growth is driven by increasing demand for ventilation and anesthesia solutions, expansion in emerging markets, and strategic acquisitions. The company's focus on innovation, particularly in digital healthcare and patient monitoring, also contributes to growth. Additionally, the rising need for critical care equipment and services, especially during the pandemic, has boosted sales.
Segment n°2 -> Safety
Expected Growth : 3 %
What the company do ?
Drägerwerk AG & Co. KGaA's Safety segment provides personal protective equipment, gas detection systems, and other safety solutions for industries and emergency services.
Why we expect these perspectives ?
Drägerwerk's Safety segment growth is driven by increasing demand for gas detection and respiratory protection products, particularly in the oil and gas, chemical, and mining industries. Additionally, the company's focus on innovation, expansion into emerging markets, and strategic acquisitions contribute to its growth.
Drägerwerk Ag & Co. Kgaa Products
| Product Range | What is it ? |
|---|---|
| Anesthesia Workstations | Dräger's anesthesia workstations provide advanced ventilation, anesthesia delivery, and patient monitoring capabilities for surgical and critical care settings. |
| Patient Monitoring Systems | Dräger's patient monitoring systems provide real-time vital sign monitoring, data analysis, and alarm management for patient care. |
| Ventilation Systems | Dräger's ventilation systems provide advanced respiratory care, including invasive and non-invasive ventilation, for patients in critical care settings. |
| Perioperative Care Solutions | Dräger's perioperative care solutions provide integrated systems for anesthesia, ventilation, and patient monitoring in surgical settings. |
| Gas Detection and Analysis | Dräger's gas detection and analysis solutions provide portable and fixed gas detection systems for industrial, oil and gas, and emergency response applications. |
| Dive Computers and Underwater Communication | Dräger's dive computers and underwater communication systems provide advanced safety and communication solutions for professional and recreational divers. |
| Fire and Emergency Services Equipment | Dräger's fire and emergency services equipment provides respiratory protection, gas detection, and communication solutions for firefighters and emergency responders. |
Drägerwerk AG & Co. KGaA's Porter Forces
Threat Of Substitutes
Drägerwerk AG & Co. KGaA operates in the medical technology industry, where substitutes are limited. However, the company faces competition from alternative medical devices and technologies.
Bargaining Power Of Customers
Drägerwerk AG & Co. KGaA's customers are primarily hospitals and healthcare providers, who have limited bargaining power due to the company's strong brand reputation and high-quality products.
Bargaining Power Of Suppliers
Drägerwerk AG & Co. KGaA relies on a diverse supplier base, which reduces the bargaining power of individual suppliers. However, the company may face challenges in sourcing high-quality components and materials.
Threat Of New Entrants
The medical technology industry has high barriers to entry, including regulatory hurdles and significant R&D investments. This limits the threat of new entrants and provides Drägerwerk AG & Co. KGaA with a competitive advantage.
Intensity Of Rivalry
The medical technology industry is highly competitive, with several established players competing for market share. Drägerwerk AG & Co. KGaA faces intense competition from companies such as Medtronic, Philips, and GE Healthcare.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 21.68% |
| Debt Cost | 3.95% |
| Equity Weight | 78.32% |
| Equity Cost | 3.09% |
| WACC | 3.28% |
| Leverage | 27.69% |
Drägerwerk AG & Co. KGaA : Quality Control
Drägerwerk AG & Co. KGaA passed 4 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| CHEMM.CO | ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in … |
| SNT.WA | Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and … |
| EUZ.DE | Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and … |
| GBT.PA | Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and … |
| ELN.MI | EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Europe and internationally. The company offers medical laser equipment for use in the fields … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
EL.En
A-Score
1-Year Total Return ->
🥈
Drägerwerk
A-Score
1-Year Total Return ->
🥉
Synektik
A-Score
1-Year Total Return ->
4
ChemoMetec
A-Score
1-Year Total Return ->
5
Guerbet
A-Score
1-Year Total Return ->
6
